However, how mutations and/or loss of CASP8 affects necroptosis in HNSCC and whether modulation of the necroptosis pathway with these small-molecule agents might have potential clinical utility in the context of CASP8 loss have largely been unexplored. Here, CASP8 is linked to head and neck squamous cell carcinoma.